Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
save over 85%
per week for 24 weeks
Welcome to
super saver spring
per week
for 24 weeks
// //


Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 2.72
Day High 2.84
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

IMV Inc. is a clinical-stage immuno-oncology company. Its proprietary drug development platform provides a patented delivery formulation which enables controlled and prolonged exposure of antigens to the immune system. The company's pipeline consists of DPX-Survivac, DPX-E7 and DPX-RSV which are in clinical stage. IMV Inc. is based in Halifax, Canada.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

IMV Inc. to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference
- BusinessWire - Tue Apr 13, 6:05AM CDT
BusinessWire - CMTX
Tue Apr 13, 6:05AM CDT
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company today announced that IMV's executive management team will be participating in the 2021 Bloom Burton & Co. Healthcare Investor Virtual Conference which will be held April 20 and April 21, 2021.
IMV Announces Company-Sponsored Clinical Trial in Patients with r/rDLBCL in Collaboration with Merck Following Feedback from FDA
- BusinessWire - Wed Apr 7, 6:05AM CDT
BusinessWire - CMTX
Wed Apr 7, 6:05AM CDT
--Patient population and clinical endpoints aligned with FDA guidance for potential path to accelerated approval
IMV Appoints Kyle Kuvalanka to Board of Directors
- BusinessWire - Thu Mar 25, 6:05AM CDT
BusinessWire - CMTX
Thu Mar 25, 6:05AM CDT
--Company advancing novel immunotherapies in oncology and infectious diseases built on its proprietary DPX platform with novel lipid-based delivery technology
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 2.68 +3.36% increase
on 04/13/21
Period Open:3.90
Price movement based on the high, low and last over the given period.
3.93 -29.52% decrease
on 03/17/21
-1.13 (-28.97%) decrease
since 03/16/21
3-Month 2.68 +3.36% increase
on 04/13/21
Period Open:3.53
Price movement based on the high, low and last over the given period.
4.60 -39.78% decrease
on 02/05/21
-0.76 (-21.53%) decrease
since 01/15/21
52-Week 1.53 +81.05% increase
on 04/17/20
Period Open:1.52
Price movement based on the high, low and last over the given period.
6.82 -59.38% decrease
on 07/14/20
+1.25 (+82.24%) increase
since 04/16/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies